baber/WOPTO huggingface dataset:
Patent PT-1497047-E (PT)
Title: Process for washing the interior of containers made of plastic material
Inventor: SPOTTI GIOVANNI
IPC: B08B9/34
Filed: 2003-03-24
Abstract: An apparatus for washing containers ( 1 ) made of plastic material with capacity ranging between 5 and 30 litres which may be provided with a handle ( 7 ) to facilitate its handling, comprises: means for gripping the container ( 1 ) in upside down condition, i.e. with the mouth ( 9 ) oriented downwards, so shaped as to allow also a rotation of the container ( 1 ) about its own central longitudinal axis; spraying means ( 4 ) for spraying suitable cleaning fluid inside the container ( 1 ) whilst said container rotates about its own central longitudinal axis, and is characterised in that the spraying means comprise at least a pair of movable nozzles ( 4 ), so shaped as to produce at least a pair of rotating jets of cleaning fluid which simultaneously penetrate inside the container ( 1 ) through the mouth ( 9 ) to clean the interior of the container ( 1 ) and of the grip ( 7 ) if present.
Patent PT-1553943-E (PT)
Title: Use of tenatoprazole for the treatment of gastroesophageal reflux
Inventor: SCHUTZE FRANCOIS
IPC: A61P11/04
Filed: 2003-10-21
Abstract: Use of tenatoprazole is claimed in medicines for the treatment of atypical and esophageal symptoms of gastroesophageal reflux, digestive hemorrhages and dyspepsias. ACTIVITY : Gastrointestinal-Gen; Antiasthmatic; Antitussive; Respiratory-Gen.; Antianginal; Hemostatic. In a test, fourteen patients suffering from gastroesophageal reflux were given a daily dose of tenatoprazole (20 mg) for 4-12 weeks. In twelve cases, the dosage was tolerated perfectly and in the other two cases it was well-tolerated. The effect on the symptoms was very good. MECHANISM OF ACTION : Proton pump inhibitor.
Patent PT-1548293-E (PT)
Title: An integrated unit for air treatment in pneumatic systems
Inventor: LUCIDERA MARCO
IPC: F15B21/041
Filed: 2004-12-13
Abstract: An integrated unit for air treatment in pneumatic systems comprises a box-shaped body provided with an inlet (11) for the air to be treated and at least one outlet (12) for the treated air and holds devices for treatment and regulation of the air flow between the inlet and outlet. The devices consist of at least one filter device (114), one pressure regulator (212) and one progressive-starting device (215). <IMAGE>
Patent PT-1515023-E (PT)
Title: An electronically controlled butterfly valve provided with a flat leaf spring and a spiral spring to establish the limp-home position
Inventor: FAUNI CLAUDIO
IPC: F02D9/10
Filed: 2004-09-14
Abstract: An electronically controlled butterfly valve (1) comprising a valve body (2), a valve seat (4) formed in the valve body (2), a butterfly disc (5) adapted to engage the valve seat (4), a shaft (6) on which the butterfly disc (5) is keyed, an electric motor (3) coupled to the shaft (6) by means of a gear transmission (8) having a final gear (18) keyed on the shaft (6), a spiral return spring (35) adapted to rotate the butterfly disc (5) towards the closed position, and an opposing spring (36) adapted to rotate the butterfly disc (5) towards a limp-home position defined by an abutment body (37) against the action of the return spring (35); the opposing spring (36) is a flat leaf spring and is mounted on a moving member (39) which is mounted coaxially and idly on the shaft (6) and has a projection (47) adapted to engage in abutment against the abutment body (37), an end (44) of the opposing spring (36) being free and ending in a projection (45) which is disposed so as to be superimposed on the trajectory followed by a member (46) rigid with the final gear (18). <IMAGE>
Patent PT-1656857-E (PT)
Title: Filling system for bodies having air core
Inventor: KURT SCHUSTER
IPC: A47C27/08
Filed: 2004-11-16
Abstract: The system has an air pump system (3) with two separate chambers (2, 6), and a control system (17), where chambers exhibit a common boundary surface. The chamber (2) is directly connected to an air core over a line (1) and the chamber (6) is connected to the core over a line (7) by a pressure adjusting valve (13). The chamber (6) is connected to ambient air over a third line (9), where an air filter (11) is provided in the line (9).
Patent PT-1554446-E (PT)
Title: Backflow prevention cap and panels having interlocking folds
Inventor: KIM YEE-HYENG
IPC: E04D1/18
Filed: 2004-06-21
Abstract: A backflow prevention cap for panels having interlocking-folds, which prevents a backflow of water into seamed panels through fine gaps between the interlocking folds of the seamed panels by wind action. Each of panels has a tetragonal panel body ( 7 ), outer interlocking folds ( 9 ) provided by folding outwardly two neighboring sides of the panel body, and inner interlocking folds, ( 11 ) provided by folding inwardly two remaining sides of the panel body. The backflow prevention cap includes a water shielding part ( 3 ) having a sheet-shaped wedge structure to be installed in the top ends of the outer interlocking folds ( 9 ) of each panel and supported in the top ends of the outer interlocking folds by a locking means when the panels are continuously seamed together through a fold-interlocking method.
Patent PT-1661719-E (PT)
Title: Manipulation and printing device and method for labels fed from label sheets
Inventor: BALLESTRAZZI ARIS
IPC: B65C11/02
Filed: 2005-11-16
Abstract: A manipulation and printing device for labels fed from label sheets, in which labels (15) are fed to a cutting group (18) placed above a feed belt (19) of suction type (20) equipped with superficial holes, placed perpendicular to the feed direction of a continuous label sheet (12), and to a labeller (30), in which it is foreseen associated to the first feed belt (19) a second feed belt (24) and a print head (23), placed near a first side end perpendicular to the feed direction of the label sheet (12), the feed belts (19, 24) being facing in one of their sections in order to advance the single printed label from the print head (23) towards the labeller (30). Furthermore, a method is realised in which labels (15) are fed to a cutting group (18) placed above a feed belt (19, 20) placed perpendicular to the feed direction of a continuous label sheet (12), and then to a labeller (30), where the method foresees a feeding of the single labels by means of the first feed belt (19) towards a print head (23) located near a first side end perpendicular to the feed direction of the label sheet (12), to print one single label after another and direct the single printed (14) labels (15) towards the labeller (30).
Patent PT-1789499-E (PT)
Title: Dye mixtures of fibre-reactive azo dyes production and use thereof
Inventor: MEIER STEFAN
IPC: C09B67/22
Filed: 2005-08-30
Abstract: The invention relates to dye mixtures, comprising one or more dyes of the following general formula (I), one or more dyes of the following general formula (II), one more dyes of the following general formula (III) and, optionally, one or more dyes of the following general formula (IV) in which D, D<SUP>1</SUP>, D<SUP>2</SUP>, D<SUP>3</SUP>, D<SUP>4</SUP>, D<SUP>5</SUP>, R<SUP>0</SUP>, R<SUP>200</SUP>, R<SUP>201</SUP>, R*, R**, T, b, f, v and M have the meanings given in claim 1, whereby the dyes of general formulae (I)-(IV) contain at least one fibre-reactive group of formula -SO<SUB>2</SUB>-Z or Z<SUP>2</SUP>, the production and use thereof for the dyeing and printing of fibre materials containing hydroxyl and/or carboxamide groups.
Patent PT-1835961-E (PT)
Title: Self-sealing male connector device with collapsible body
Inventor: RAYBUCK JOHN
IPC: A61M39/26
Filed: 2005-12-16
Abstract: A self-sealing male connector device for connection with a female Luer connector. The device has an elongated male body configured with lengthwise relatively rigid and flexible wall segments cooperating to allow the body to be radially compressed from an expanded configuration to a contracted configuration. A closure cap formed with a resealable aperture is disposed on the distal end of the male body so as to be responsive to the compression of the male body. The relatively flexible wall segments may be installed within notches in the male body or be formed integral with the relatively rigid wall segments.
Patent PT-2014293-E (PT)
Title: Use of argon in gaseous state to treat neurointoxication
Inventor: LEMAIRE MARC
IPC: A61K33/00
Filed: 2004-12-01
Abstract: Argon gas is used to make an inhalable medicament for preventing or treating neuro-intoxication in humans. An independent claim is also included for a gas mixture containing argon as an inhalable medicament for preventing or treating neuro-intoxication in humans. ACTIVITY : Antiaddictive; Antismoking; Antialcoholic; Cerebroprotective; Neuroprotective; Nootropic; Antiparkinsonian; Anticonvulsant; Tranquilizer; Neuroleptic. The locomotor activity of rats pretreated with d-amphetamine (1 mg/kg), then exposed to an atmosphere of 75% argon and 25% oxygen and then challenged with d-amphetamine (1 mg/kg) was about 900 actimetric units, compared with about 1500 units for pretreated with d-amphetamine (1 mg/kg), then exposed to an air atmosphere and then challenged with d-amphetamine (1 mg/kg). MECHANISM OF ACTION : None given.
Patent PT-2311023-E (PT)
Title: A device for displaying a flag
Inventor: SANVIK THOMAS
IPC: G09F17/00
Filed: 2009-06-18
Abstract: A device for displaying a flag includes a raisable and lowerable flag container (12) provided with an arrangement for extending or retracting a flag, and a raisable and lowerable flag cassette (6) provided with several flag containers (12). The device for displaying a flag is provided with a control unit (5) from which the device for displaying a flag may be controlled. The flag container (12) in the flag cassette is provided with a device for pivoting the flag container from being essentially parallel to the flag pole into an essentially orthogonal angle relative to the flag pole and a device for extending or retracting a flag in the flag container, where the control unit (5) is arranged to first pivoting a flag container and then extending a flag in the flag container.
Patent PT-658118-E (PT)
Inventor: JENNINGS HAROLD
IPC: A61P31/04
Filed: 1993-08-30
Abstract: An immunogenic conjugate comprising a modified group C meningococcal polysaccharide (GCMP) coupled to a carrier molecule. The GCMP is modified by O-deacetylation to a varying extent. This modified GCMP conjugate stimulates a strong immunogenic response. The antiserum, produced by immunization with this conjugate, is cross-reactive with the native polysaccharide. In addition, these antisera elicit a class of antibodies that have potent bactericidal activity.
Patent PT-820461-E (PT)
Inventor: MCGUIGAN CHRISTOPHER
IPC: A61K31/7072
Filed: 1996-03-13
Abstract: Aryl substituted phosphoryl derivatives of the formula In which Ar is phenyl, naphthyl, or pyridyl, Y is O or S, X<SUP>1 </SUP>is O, NR<SUP>3</SUP>, S, CR<SUP>3</SUP>R<SUP>4</SUP>, CR<SUP>3</SUP>W<SUP>1 </SUP>or CW<SUP>1</SUP>W<SUP>2</SUP>, X<SUP>2 </SUP>and X<SUP>6 </SUP>are a bond or X<SUP>6 </SUP>is CH<SUB>2 </SUB>and X<SUP>2 </SUP>is O, NR<SUP>3</SUP>, S, CR<SUP>3</SUP>R<SUP>4</SUP>, CR<SUP>3</SUP>W<SUP>1 </SUP>or CW<SUP>1</SUP>W<SUP>2</SUP>, R<SUP>3 </SUP>and R<SUP>4 </SUP>are H, alkyl or phenyl, groups, W<SUP>1 </SUP>and W<SUP>2 </SUP>are heteroatoms, X<SUP>3 </SUP>is alkylene, X<SUP>4 </SUP>is oxygen or CH<SUB>2</SUB>, X<SUP>5 </SUP>is a bond or CH<SUB>2</SUB>, Z is O, NR<SUP>5</SUP>, S, alkyl or phenyl, R<SUP>5 </SUP>is H, alkyl or phenyl, J is H, alkyl, phenyl, or a heterocyclic or polycyclic group, Q is O, NR<SUP>6</SUP>, S, CR<SUP>6</SUP>R<SUP>7</SUP>, CR<SUP>6</SUP>W<SUP>3 </SUP>or CW<SUP>3</SUP>W<SUP>4</SUP>, R<SUP>6 </SUP>and R<SUP>7 </SUP>are H, alkyl or phenyl, and W<SUP>3 </SUP>and W<SUP>4 </SUP>are hetero atoms, T<SUP>1 </SUP>and T<SUP>2 </SUP>are H or CH<SUB>2</SUB>R<SUP>8</SUP>, R<SUP>8 </SUP>is H, OH or F, or T<SUP>1 </SUP>and T<SUP>2 </SUP>together are -CH-CH- or -C(R<SUP>9</SUP>)(R<SUP>10</SUP>)C(R<SUP>11</SUP>)(R<SUP>12</SUP>)-, R<SUP>9 </SUP>is H, halogeno, CN, NH<SUB>2</SUB>, CO-alkyl, or alkyl, R<SUP>10</SUP>, R<SUP>11</SUP>, and R<SUP>12 </SUP>are H, N<SUB>3</SUB>, halogen, CN, NH<SUB>2</SUB>, CO-alkyl, or alkyl, and B is a purine or pyrimidine base, have antiviral activity, as for example against HIV. Particularly preferred are thymine and adenine derivatives of amino acid phenoxyphosphoroamidates. A typical embodiment is 2',3'-dideoxy-2',3'-didehydrothymidine 5'-(phenyl methoxy alaninyl) phosphoroamidate which can be prepared from phenyl methoxy alaninyl phosphorochloridate and 2',3'-dideoxy-2',3'-didehydrothymidine.
Patent PT-844971-E (PT)
Inventor: MONEY JULIAN DAVID KYRLE
IPC: B65D5/36
Filed: 1996-08-09
Abstract: PCT No. PCT/GB96/01941 Sec. 371 Date Feb. 18, 1998 Sec. 102(e) Date Feb. 18, 1998 PCT Filed Aug. 9, 1996 PCT Pub. No. WO97/07037 PCT Pub. Date Feb. 27, 1997The disclosure relates to a pack for articles of food or other merchandise comprising a bag (30) and a carton form (40) for supporting a lower part of the bag having a base (41) with a central fold line (32) and walls (43) hinged to the base along further fold lines (44) to enable the carton and bag to be folded flat and to be erected to open the bag. The side walls of the lower part of the bag are secured to the side walls of the carton so that when the carton is erected by opening the folded base into a V-form, the bottom part of the bag is opened, and, as the V-form is progressively widened, the bag is tensioned by the walls moving apart until the base of the carton moves "over center" and inverts to brace the lower part of the bag open to receive an article or articles to be packed therein.
Patent PT-883477-E (PT)
Inventor: AUER HANS
IPC: B29C37/00
Filed: 1997-01-30
Abstract: The invention concerns a method of producing moulded bodies (18) provided with printed labels according to the so-called in-mould labelling (IML) method, in which printed labels (23) are produced by printing a printed layer (14) onto an oriented carrier foil (10) made of a thermoplastic polymer. The printed labels (23) are placed in a mould (16) and connected in a material-bonded manner to a moulded body (18) which is introduced into the mould (16, 24) and is moulded at high temperatures. The surface of the printed moulded body is provided with a high-gloss surface by coating the labels with a transparent covering layer (20) after the printed layer (14) has been applied and before the labels are placed in the mould (16, 24).
Patent PT-925418-E (PT)
Inventor: APPELTANS GUY
IPC: E05G1/14
Filed: 1997-08-26
Abstract: The invention concerns a protective device for valuable documents, including a volume capable of being closed and divided into two compartments, one of the compartments being used to receive the documents to be protected while in the second compartment caps contain a pyrotechnic mixture which, when the device is wrongly manipulated, will burst into a flame which will penetrate the documents in the first mentioned compartment.
Patent PT-952619-E (PT)
Inventor: LAHME NORBERT
IPC: H01M2/12
Filed: 1998-04-20
Abstract: A catalytic hydrogen/oxygen recombination unit (1) for batteries has a space (6) connected to the battery connection channel by an opening and to the atmosphere by an ignition suppressing element.
Patent PT-931830-E (PT)
Inventor: FRANCIS MCCORMICK
IPC: A61K35/76
Filed: 1994-02-16
Abstract: Methods and compositions for treating neoplastic conditions by viral-based therapy are provided. Mutant virus lacking viral proteins which bind and/or inactivate p53 or RB are administered to a patient having a neoplasm which comprises cells lacking p53 and/or RB function. The mutant virus is able to substantially produce a replication phenotype in neoplastic cells but is substantially unable to produce a replication phenotype in non-replicating, non-neoplastic cells having essentially normal p53 and/or RB function. The preferential generation of replication phenotype in neoplastic cells results in a preferential killing of the neoplastic cells, either directly or by expression of a cytotoxic gene in cells expressing a viral replication phenotype.
Patent PT-955049-E (PT)
Inventor: WINKLEY MICHAEL WILLIAM
IPC: C07J71/00
Filed: 1995-04-28
Abstract: A process for the production of medrogestone, in which, in an intermediate step, the solvate 3 beta ,5 alpha ,6 beta -trihydroxy-6 alpha ,17 alpha -dimethylpregnan-20-one monomethanolate is obtained as a solid, stable compound by displacing the organic solvent from a solution of of 3 beta ,5 alpha ,6 beta -trihydroxy-6 alpha ,17 alpha -dimethylpregnan-20-one with a lower alkanol, and a Diels-Alder adduct of 6-methylene-17 alpha -methylpregn-4-ene-3,20-dione with maleic anhydride is used as an intermediate for production of the corresponding dicarboxylic acid salt for removal of 6-methylene-17 alpha -methylpregn-4-ene-3,20-dione contamination of the desired product. Another intermediate, 6 beta -hydroxy-6 alpha ,17 alpha -dimethylpregn-4-ene-3,20-dione, has been found to prevent smooth muscle proliferation and is useful in the treatment of atherosclerosis and restinosis.
Patent PT-1053447-E (PT)
Inventor: SCHNELL WOLFGANG
IPC: B65G43/02
Filed: 1999-01-25
Abstract: The present invention relates to a device for continuously monitoring the junction of a conveyor belt which is made of rubber or a rubber-type plastic material and which comprises supports inserted therein for reinforcing the same. In an advantageous embodiment, the device essentially comprises the following constituent members for the junction area: mainly four reference marks, two addresses as well as four detection heads, the heads being located above the carrier surface of the conveyor belt. This invention further relates to other advantageous embodiments of this device.
Patent PT-1094781-E (PT)
Title: Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
Inventor: KIRBY KENNETH B
IPC: A61L15/44
Filed: 1999-07-07
Abstract: A transdermal delivery system (TDS)for use in treatment of living bodies may be applied as an open (liquid, gel) or closed (patch) article. The TDS is composed of a particular active agent which dictates an associated selection of certain solvents, solvent modifiers, solute modifiers and skin stabilizers with which the medicament forms a true solution that rapidly crosses the skin barrier. The associated selection of the particular solvents, solvent modifiers, solute modifiers and skin stabilizers is based on a balancing of the molecular properties of all the components against the molecular properties of all the components plus the particular active agent. The TDS may also include a source of cellular energy to induce CAMP or cGMP. The TDS improves delivery of active agents having a molecular weight greater than 340 Daltons and increases dosage above 0.25 mg/day for such active agents.
Patent PT-1119612-E (PT)
Title: Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using the same
Inventor: DEBARTOLOMEIS JAMES
IPC: C07K14/505
Filed: 1999-10-04
Abstract: Disclosed and claimed is a new insect cell line, Sf900+, ATCC CRL-12579. The insect cell line was established from Lepidoptera, Noctuidae, Spodoptera frugiperda Sf-9 (ATCC CRL-1711) through multiple rounds of limiting dilution and selection in a serum-free insect medium supplemented with added human insulin. The insect cell line is useful in BEVS or as an adjuvant and has many characteristics and advantages. Also disclosed and claimed are recombinant proteins from recombinant baculovirus expression in insect cells such as Sf900+ cells, for instance, HA, NA, EPO, CD4, CEA, and thrombospondin.
Patent PT-1140719-E (PT)
Inventor: VITTER GERARD
IPC: B32B15/04
Filed: 1999-10-06
Abstract: The invention concerns a sheet metal enamelled on both surfaces, the enamel comprising a vitreous phase wherein is dispersed at least a crystallised mineral compound which, at 300  DEG C, has a protonic conductivity higher than 10<-6> S.cm<-1>, and which is dispersed in a proportion sufficient for providing the enamel with impermeability to hydrogen higher than 10<-11> g.cm<-2>.s<-1> in the range of temperatures between 300  DEG C and the enamel glass transition temperature. The invention also concerns the enamel composition and a method for making said sheet. The invention enables enamelling grades of steel considered to be enamel-resistant.
Patent SG-27993-G (SG)
Title: Waste material collecting bin
IPC: B65F7/00
Filed: 1993-03-17
Abstract: A waste material collecting bin has a storage container (24) for containing waste material fed into it via a rotary inlet valve (22). Prior to dropping into the container waste material rests on the valve adjacent the inlet and is there sprayed with treating substance drawn from a reservoir (19)
Patent IE-780091-L (IE)
Title: Esters, alcohol
IPC: C07C69/74
Filed: 1978-01-16
Abstract: New insecticides, organic esters wherein the alcohol moiety is alpha -trifluoromethyl-3-phenoxybenzyl alcohol and the acid moiety is a pyrethroid carboxylic acid, are described and shown to control a broad spectrum of insects, including acarids.
[US4152455A]
Patent IE-840302-L (IE)
Title: 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
IPC: C07D223/16
Filed: 1984-02-09
Abstract: Variously substituted 1-carboxymethyl-3-(carboxymethylamino)-2,3,4,5-tetrahydro-1H-[1]benzaz epin-2-ones and functional derivatives are angiotensin converting enzyme inhibitors and are useful as antihypertensive agents. Synthesis of, compositions and methods of treatment utilizing such compounds are included.
[US4473575A]
Patent IE-34185-L (IE)
Title: Catalytic epoxidation of olefins.
IPC: C07B61/00
Filed: 1970-04-01
Abstract: 1,249,079. Epoxidation catalysts. SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ N.V. 1 April, 1970 [2 April, 1969], No. 15373/70. Heading B1E. [Also in Division C2] Catalysts used in the epoxidation of olefinic compounds with organic hydroperoxides comprise titanium in chemical combination with a solid silica and/or an inorganic silicate. In addition the catalyst may contain a promoter e.g. a compound of magnesium, calcium, strontium or barium and also an oxide or hydroxide of boron, tin, miobium, tantalum, chromium, molybdenum, rhenium, uranium, bismuth or rare earth metals (atomic numbers 57-71). Preferably the catalyst has a specific surface area of at least 1m<SP>2</SP>/g. In the examples catalysts are used comprising in addition to the titanium compound the following:-(a) zirconium, (b) niobium, (c) boron, (d) tin, (e) "didymium" (a complex mixture of rare earth metals), (f) molybdenum, (g) molybdenum and didymium and (h) alumina alone or with magnesium or calcium. For comparative purposes examples are given of the use of other catalysts e.g. mixtures of titania and silica or silicates, various other metals are silica and various metal compounds without silica.
[GB1249079A]
Patent IE-35594-L (IE)
Title: N-(bicycloamino-alkanoyl)-anilines
IPC: C07D215/06
Filed: 1971-09-03
Abstract: Compounds of the class of N-(bicycloamino-alkanoyl)-anilines useful as local anesthetic and anti-arrhythmic agents.
[US3679686A]